STOCK TITAN

DelphX Announces Grant of Stock Options

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) announces the approval of 2,325,000 stock options for eligible participants under its stock option plan.
Positive
  • None.
Negative
  • None.

Toronto, Ontario--(Newsfile Corp. - December 8, 2023) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products for the fixed income market, announces that its Board of Directors has approved the grant of 2,325,000 stock options (the "Options") to eligible participants under its stock option plan (the "Plan"). The Options have a two-year maturity and are exercisable for common shares of DelphX at an exercise price of $0.25 per common share, all in accordance with the Plan.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables fixed income dealers to offer new private placement securities that optimally transfer and diffuse credit risk, while allowing the enhancement of returns. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

  • Collateralized put options (CPOs) that provide rating change protection for underlying corporate bonds;
  • Collateralized reference notes (CRNs) that enable hedge funds and others to take on rating downgrade exposure of an underlying corporate bond in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com.

William Hahn, Chief Financial Officer
DelphX Capital Markets Inc.

(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/190426

FAQ

What is the latest announcement from DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF)?

DelphX announces the approval of 2,325,000 stock options for eligible participants under its stock option plan.

How many stock options have been approved by DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF)?

2,325,000 stock options have been approved.

What is the maturity period for the approved stock options by DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF)?

The approved stock options have a two-year maturity period.

At what exercise price are the stock options exercisable for common shares of DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF)?

The stock options are exercisable at an exercise price of $0.25 per common share.

What is the purpose of the stock options approved by DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF)?

The stock options are approved for eligible participants under its stock option plan.

DelphX Capital Markets Inc.

OTC:DPXCF

DPXCF Rankings

DPXCF Latest News

DPXCF Stock Data

14.03M
72.59M
36.55%
14.45%
Investment Banking and Securities Dealing
Finance and Insurance
Link
United States of America
Toronto